Filtriraj po Last updated date SelectPoznejePredFrom - To Date Končni datum This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Rezultati (3838) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank European Medicines Agency closed 26 August 2013 22 Avgust 2013NewsCorporateMedicines European Medicines Agency and US Food and Drug Administration release first conclusions of parallel assessment of quality-by-design applications 20 Avgust 2013NewsHumanMedicines European Medicines Agency publishes reflection paper on general issues for consideration regarding coated nanomedicines 15 Avgust 2013NewsHumanMedicines Workshop on conflicts of interests: deadline for registration extended 14 Avgust 2013NewsCorporate 'Send a question' form working again 14 Avgust 2013NewsCorporate Regulatory information - Revised dossier-submission requirements for active-substance master files 14 Avgust 2013NewsCorporate 'Send a question' form not working 9 Avgust 2013NewsCorporate Regulatory information - European Medicines Agency publishes guidance on validation process for initial marketing authorisation 5 Avgust 2013NewsHumanMedicines Guideline on medicines for the treatment of amyotrophic lateral sclerosis released for a six-month public consultation 1 Avgust 2013NewsHuman Concept paper on development of product-specific guidance on demonstration of bioequivalence released for a two-month public consultation 1 Avgust 2013NewsHuman 1 … 220 221 222 223 224 Page 224 of 384 225 226 227 228 … 384
European Medicines Agency and US Food and Drug Administration release first conclusions of parallel assessment of quality-by-design applications 20 Avgust 2013NewsHumanMedicines
European Medicines Agency publishes reflection paper on general issues for consideration regarding coated nanomedicines 15 Avgust 2013NewsHumanMedicines
Regulatory information - Revised dossier-submission requirements for active-substance master files 14 Avgust 2013NewsCorporate
Regulatory information - European Medicines Agency publishes guidance on validation process for initial marketing authorisation 5 Avgust 2013NewsHumanMedicines
Guideline on medicines for the treatment of amyotrophic lateral sclerosis released for a six-month public consultation 1 Avgust 2013NewsHuman
Concept paper on development of product-specific guidance on demonstration of bioequivalence released for a two-month public consultation 1 Avgust 2013NewsHuman
